Marion Ott

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1

Marion Ott, Manfred Schmidt, Kerstin Schwarzwaelder et al. · Nature Medicine · 2006 · 1.2K citations

Life Sciences, Immunology, Molecular Medicine +10

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

Stefan Stein, Marion Ott, Stephan Schultze‐Strasser et al. · Nature Medicine · 2010 · 784 citations

Medicine, Genetics, Molecular Genetics +16

Economic Games: An Introduction and Guide for Research

Isabel Thielmann, Robert Böhm, Marion Ott et al. · Collabra Psychology · 2021 · 117 citations · Full text

Social Sciences, Psychology, Social Psychology +10

Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial

Naval Daver, Monique Dail, Jacqueline S. Garcia et al. · Blood · 2022 · 102 citations · Full text

Medicine, Oncology, Pharmacology +17

Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites

Marion Ott, Frederik Marmé, Gerhard Moldenhauer et al. · International Journal of Cancer · 2011 · 76 citations · Full text

Life Sciences, Immunology, Oncology +15